Veerhealth Care Ltd — Important, 17-08-2026: Company Update

Veerhealth Care reported robust financial results for the quarter, with total revenues surging 388.13% to ₹25.09 Cr, EBITDA up 233.87% to ₹2.07 Cr, and Net Profit increasing 412.50% to ₹1.23 Cr. The company secured significant orders, including ₹32.93 Cr for body care products from a New York-based company, ₹18.24 Cr for skincare from an Indian FMCG, and ₹1.11 Cr from a major Indian retail pharmacy network. A sample export order of ₹0.16 Cr for Gripe Water marks its entry into the Sudan market. Operational highlights include USFDA clearance enabling drug exports to the USA, advanced talks for Russian oral care exports, and expanded e-commerce presence.